pervanadate and Leukemia--Myeloid--Acute

pervanadate has been researched along with Leukemia--Myeloid--Acute* in 1 studies

Other Studies

1 other study(ies) available for pervanadate and Leukemia--Myeloid--Acute

Article	Year
Direct effect of bispecific anti-CD33 x anti-CD64 antibody on proliferation and signaling in myeloid cells. Leukemia research, 2001, Volume: 25, Issue:12 Bispecific anti-CD33 x anti-CD64 antibody (BsAb) directly inhibited proliferation and colony formation of human acute myeloid leukemia cell lines, without affecting the function of normal monocytes. Addition of BsAb to normal monocytes induced tyrosine phosphorylation of Cbl and Vav, association of these molecules with CD33, and downstream signaling. In leukemia cells that were insensitive to BsAb treatment, Vav and Cbl were constitutively phosphorylated and, therefore, constitutively associated with CD33. Direct growth inhibition is an additional mechanism by which BsAb may be useful in the therapy of AML. Topics: Antibodies, Bispecific; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Division; Humans; Interferon-gamma; Leukemia, Myeloid, Acute; Monocytes; Phagocytosis; Phosphorylation; Receptors, IgG; Sialic Acid Binding Ig-like Lectin 3; Tumor Cells, Cultured; Tyrosine; Vanadates	2001

Article

Year

Direct effect of bispecific anti-CD33 x anti-CD64 antibody on proliferation and signaling in myeloid cells.

Leukemia research, 2001, Volume: 25, Issue:12

Bispecific anti-CD33 x anti-CD64 antibody (BsAb) directly inhibited proliferation and colony formation of human acute myeloid leukemia cell lines, without affecting the function of normal monocytes. Addition of BsAb to normal monocytes induced tyrosine phosphorylation of Cbl and Vav, association of these molecules with CD33, and downstream signaling. In leukemia cells that were insensitive to BsAb treatment, Vav and Cbl were constitutively phosphorylated and, therefore, constitutively associated with CD33. Direct growth inhibition is an additional mechanism by which BsAb may be useful in the therapy of AML.

Topics: Antibodies, Bispecific; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Division; Humans; Interferon-gamma; Leukemia, Myeloid, Acute; Monocytes; Phagocytosis; Phosphorylation; Receptors, IgG; Sialic Acid Binding Ig-like Lectin 3; Tumor Cells, Cultured; Tyrosine; Vanadates

2001